ATE534909T1 - Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren - Google Patents

Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren

Info

Publication number
ATE534909T1
ATE534909T1 AT05855111T AT05855111T ATE534909T1 AT E534909 T1 ATE534909 T1 AT E534909T1 AT 05855111 T AT05855111 T AT 05855111T AT 05855111 T AT05855111 T AT 05855111T AT E534909 T1 ATE534909 T1 AT E534909T1
Authority
AT
Austria
Prior art keywords
amino acids
natural amino
proteins
proteomic profiling
reagents
Prior art date
Application number
AT05855111T
Other languages
English (en)
Inventor
Aaron J Link
Erin Schuman
David Tirrell
Daniela C Dieterich
Original Assignee
California Inst Of Techn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Inst Of Techn filed Critical California Inst Of Techn
Application granted granted Critical
Publication of ATE534909T1 publication Critical patent/ATE534909T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Genetics & Genomics (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05855111T 2004-12-22 2005-12-21 Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren ATE534909T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63885604P 2004-12-22 2004-12-22
US66847105P 2005-04-05 2005-04-05
PCT/US2005/046496 WO2006069203A2 (en) 2004-12-22 2005-12-21 Methods for proteomic profiling using non-natural amino acids

Publications (1)

Publication Number Publication Date
ATE534909T1 true ATE534909T1 (de) 2011-12-15

Family

ID=36602311

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05855111T ATE534909T1 (de) 2004-12-22 2005-12-21 Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren

Country Status (4)

Country Link
US (3) US20060216760A1 (de)
EP (2) EP2290369B1 (de)
AT (1) ATE534909T1 (de)
WO (1) WO2006069203A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
WO2003067210A2 (en) 2001-07-10 2003-08-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting the activation state of the multiple proteins in single cells
US7393656B2 (en) 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
ATE534909T1 (de) 2004-12-22 2011-12-15 California Inst Of Techn Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren
US8367588B2 (en) * 2005-10-12 2013-02-05 The Scripps Research Institute Selective posttranslational modification of phage-displayed polypeptides
WO2007047668A2 (en) * 2005-10-14 2007-04-26 California Institute Of Technology Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells
EP2060584A1 (de) * 2007-10-16 2009-05-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Herstellung von Proteinen mit chemisch funktionalisierten N-Termini
EP2630196B1 (de) 2010-10-20 2017-09-06 Li-Cor, Inc. Cyaninfarbstoffe und deren konjugate
WO2015128723A1 (en) * 2014-02-28 2015-09-03 Dh Technologies Development Pte. Ltd. Microbial identification and quantitation using ms cleavable tags
WO2018042454A2 (en) * 2016-09-01 2018-03-08 Translational Health Science And Technology Institute (Thsti) Method of hyperplexing in mass spectrometry to elucidate temporal dynamics of proteome
JP7609793B2 (ja) * 2019-03-04 2025-01-07 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー バイオコンジュゲーションのために操作されたｃｄ４７の細胞外ドメイン
JP7728251B2 (ja) * 2019-10-15 2025-08-22 ジュニャーナ セラピューティクス インコーポレイテッド 反応性アフィニティプローブ相互作用探索プラットフォーム
CN115485286B (zh) * 2020-02-17 2026-01-16 南通壹宸生物医药科技有限公司 基于光交联的表位靶向抗体筛选方法
CN114075588B (zh) * 2020-07-29 2024-07-09 中国科学院上海有机化学研究所 一种高特异性的细胞分泌蛋白富集方法
DE202022003066U1 (de) 2021-04-01 2024-09-19 The Regents Of The University Of California Genetische Modifikation von Säugerzellen zur Verleihung von Resistent gegen CSF1R-Antagonisten
JP7790088B2 (ja) * 2021-10-27 2025-12-23 東ソー株式会社 セクレトーム検出方法及びｔ細胞標識用培地

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6013434A (en) * 1989-12-22 2000-01-11 Howard Florey Institute Of Experimental Physiology And Medicine Oligonucleotide-polyamide conjugates
US6596476B1 (en) * 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
US5326856A (en) 1992-04-09 1994-07-05 Cytogen Corporation Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
US5538897A (en) 1994-03-14 1996-07-23 University Of Washington Use of mass spectrometry fragmentation patterns of peptides to identify amino acid sequences in databases
US5986076A (en) 1994-05-11 1999-11-16 Trustees Of Boston University Photocleavable agents and conjugates for the detection and isolation of biomolecules
JPH10507160A (ja) 1994-06-23 1998-07-14 アフィマックス テクノロジーズ エヌ．ブイ． 光活性化合物およびその使用方法
US5846782A (en) * 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US8409564B2 (en) * 1999-10-05 2013-04-02 Universite De Montreal Rhodamine derivatives for photodynamic diagnosis and treatment
US6570040B2 (en) 2000-03-16 2003-05-27 The Regents Of The University Of California Chemoselective ligation
US6586207B2 (en) 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
EP1383802A4 (de) * 2001-03-30 2005-08-03 Univ California Anti-muc-1-einzelkettenantikörper zum targeting von tumoren
WO2003073238A2 (en) 2002-02-27 2003-09-04 California Institute Of Technology Computational method for designing enzymes for incorporation of amino acid analogs into proteins
US7449558B2 (en) * 2003-10-30 2008-11-11 National University Of Singapore Site-specific labelling of proteins
US20060057069A1 (en) * 2004-06-07 2006-03-16 California Institute Of Technology Detection of protein expression in vivo using fluorescent puromycin conjugates
WO2006091214A2 (en) * 2004-06-18 2006-08-31 Molecular Probes, Inc. Fluorescent isotope tags and their method of use
EP1812031B1 (de) * 2004-11-01 2015-06-24 The Regents of the University of California Zusammensetzungen und verfahren zur modifizierung von biomolekülen
ATE534909T1 (de) 2004-12-22 2011-12-15 California Inst Of Techn Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren

Also Published As

Publication number Publication date
WO2006069203A2 (en) 2006-06-29
WO2006069203A3 (en) 2007-02-22
US20060216760A1 (en) 2006-09-28
EP2290369A1 (de) 2011-03-02
US20210223252A1 (en) 2021-07-22
EP2290369B1 (de) 2013-08-14
EP1828780B1 (de) 2011-11-23
EP1828780A2 (de) 2007-09-05
US20170292958A1 (en) 2017-10-12

Similar Documents

Publication Publication Date Title
NO20001052D0 (no) 1C, 15N, 2H merkede proteiner for NMR-strukturbestemmelser og deres fremstilling
WO2006069203A3 (en) Methods for proteomic profiling using non-natural amino acids
ATE393237T1 (de) Mittel und verfahren zur in-vitro-bestimmung von camp
ATE394680T1 (de) Verfahren und vorrichtung zur charakterisierung von analyten
NZ591415A (en) Haemophilus influenzae type B
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
NO20051685L (no) In vitro peptidekspresjonsbibliotek
NO996425D0 (no) Metode for sekvensanalyse
DE60114018D1 (de) Von zellen präsentierte peptide
WO2001064738A3 (fr) Sequences d"acides amines derivees des proteines humaines reagissant avec l"heparine facilitant le transfert de substances d"interet a l"interieur des cellules et/ou des noyaux cellulaires
WO2002044354A3 (en) Molecules of the card-related protein family and uses thereof
ATE506370T1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
DE60333486D1 (de) Fluoreszenzproteine aus copepoda-spezies und verfahren zur verwendung davon
EP1243923A4 (de) VERFAHREN ZUM AUFFINDEN EINES HEILMITTELS FÜR KREBS MIT HILFE VON INTERAKTIONSDOMÄNEN VON p53 UND MORTALIN
WO2002093166A8 (de) Verfahren zur qualitativen und/oder quantitativen bestimmung von gattung, art, rasse und/oder geographischer herkunft biologischer materialien
WO2005018552A3 (en) Heparin binding proteins: sensors for heparin detection
EP2628750A3 (de) Gezielte Identifikation von immunogenen Peptiden
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
WO2003082897A3 (en) Synthetic active peptide fragments
WO2004094989A3 (en) Methods of host cell protein analysis
ATE269905T1 (de) Verfahren zur herstellung von proteinen in wirtszellen unter verwendung von chaperoninen
ATE556135T1 (de) Neues protein
WO2007030771A3 (en) Targeted identification of immunogenic peptides
ATE338764T1 (de) Vorrichtung von peptid- oder proteindarstellung, verfahren zu deren herstellung und deren verwendung